Comparison of QuantiFERON and tuberculin skin test for tuberculosis infection;Sammenligning af QuantiFERON og hudtest ved mulig tuberkuloseinfektion

Ugeskrift for Laeger

Volumn 171, Issue 37, 2009, Pages 2625-2625

  Jepsen, Micha ^a   Krause, Tyra Grove ^b   Moryl, Dorte ^c   Seersholm, Niels ^d   Ruhwald, Morten ^e   Søborg, Bolette ^f   Brock, Inger ^g   Ravn, Pernille ^e  

^a HVIDOVRE HOSPITAL   (Denmark)

^b Klinisk Forskningscenter ^*  (Denmark)

^c Hvidovre Lungeklinik   (Denmark)

^d Sundhedsstyrelsen   (Denmark)

^e GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^f STATENS SERUM INSTITUT   (Denmark)

^g Afdeling for Klinisk Mikrobiologi   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GAMMA INTERFERON;

ADOLESCENT; ADULT; ARTICLE; BLOOD; COMPARATIVE STUDY; DENMARK; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNOLOGY; FEMALE; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; LUNG TUBERCULOSIS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; QUESTIONNAIRE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; DENMARK; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; QUESTIONNAIRES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 70349303353     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Brock I, Ruhwald M, Lundgren B et al. Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test. Respir Res 2006;7:56.
2. Diel R, Nienhaus A, Lange C et al. Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons. Respir Res 2006;7:77.
3. Mazurek GH, Weis SE, Moonan PK et al. Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis. Clin Infect Dis 2007;45:837-45.
4. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007;146:340-54.
5. Nakaoka H, Lawson L, Squire SB et al. Risk for tuberculosis among children. Emerg Infect Dis 2006;12:1383-8.
6. Soborg B, Andersen AB, Larsen HK et al. Detecting a low prevalence of latent tuberculosis among health care workers in Denmark detected by M. tuberculosis specific IFN-gamma whole-blood test. Scand J Infect Dis 2007;39:554-9.
7. Zellweger JP, Zellweger A, Ansermet S et al. Contact tracing using a new T-cell-based test: better correlation with tuberculosis exposure than the tuberculin skin test. Int J Tuberc Lung Dis 2005;9:1242-7.
8. Arend SM, Thijsen SF, Leyten EM et al. Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med 2007;175:618-27.
9. Detjen AK, Keil T, Roll S et al. Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis 2007;45:322-8.
10. Ravn P, Munk ME, Andersen AB et al. Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clin Diagn Lab Immunol 2005;12:491-6.
11. Brock I, Weldingh K, Lillebaek T et al. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med 2004;170:65-9.
12. Adetifa IM, Lugos MD, Hammond A et al. Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in the Gambia. BMC Infect Dis 2007;7:122.
13. Rangaka MX, Wilkinson KA, Seldon R et al. Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med 2007;175:514-20.
14. Doherty TM, Demissie A, Olobo J et al. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol 2002;40:704-6.
15. Wilkinson D, Squire SB, Garner P. Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials. BMJ 1998;317:625-9.
16. Woldehanna S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev 2004:CD000171.
17. Diel R, Loddenkemper R, Meywald-Walter K et al. Predictive value of a whole-blood IFN-gamma assay for the development of active TB disease. Am J Respir Crit Care Med. 2008;177:1164-70.
18. Ferrara G, Losi M, Meacci M et al. Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 2005;172:631-5.
19. Matulis G, Juni P, Villiger PM et al. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases performance of a mycobacterium tuberculosis antigen specific IFN-gamma assay. Ann Rheum Dis 2008;67:84-90.
20. Kobashi Y, Mouri K, Obase Y et al. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients. Eur Respir J 2007;30:945-50.